title: Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
abstract: The aim of this study was to determine the blood pressure (BP) profiles and their impact on mortality among a cohort of uremic diabetics treated by hemodialysis. The studied population includes all type II diabetics starting hemodialysis for end-stage renal disease between 1990 and 1996. There were 221 patients (144 men, 77 women) aged from 37 to 78 years, were all followed until death or December 2003 without any censored data. Survival analysis to identify predictors of death was performed using the actuarial method, Cox proportional model, including systolic, diastolic, mean, and pulse blood pressures (SBP, DBP, MBP, PP). One hundred seventy-eight patients (80.5%) were hypertensive at the start of dialysis. Hypertension preceded the diagnosis of diabetes in eight cases (4.5%); 154 patients (86.5%) received antihypertensive drugs and only 23 (14.9%) had well-controlled hypertension. Our population was subdivided into four groups according to their BP levels at the time of beginning of dialysis; G1 (19.5%): normal BP (SBP [90 to 140] and DBP [60 to 90]); G2 (30.3%): Hypertension stage 1 (SBP [140 to 160] and/or DBP [90 to 100]); G3 (32.1%): hypertension stage 2 (SBP [160 to 180] and/or DBP [100 to 110]); G4 (18.1%) hypertension stage 3 (SBP [180 to 220] and/or DBP [110 to 120]). Mean age and comorbidities were similar among the four groups. During a cumulative follow-up period of 872 patient-years, 191 patients died, representing a rate of 21.9 per 100 patient-years; 20.42% of these deaths occurred during the first 3 months of dialysis. Normotensive patients showed lower survival rates without any significant difference in comparison with those of other hypertensive groups. None of the initial BP parameters (SBP, DBP, PP, MBP, hypertension stages) seemed to influence early or global mortalities, which were rather related to the urgent onset of renal replacement therapy, to age, to serum albumin, and to the score of associated morbidities. We conclude that mortality of our hemodialyzed diabetics was not influenced by the blood pressure parameters recorded at the onset of dialysis.
authors.affiliation: Department of Nephrology and Internal Medicine, Charles Nicolle Hospital, Tunis, Tunisia. abderrahim.ezzeddine@ms.tn
authors.forename: E
authors.initials: E
authors.lastname: Abderrahim
authors.forename: K
authors.initials: K
authors.lastname: Zouaghi
authors.forename: A
authors.initials: A
authors.lastname: Kheder
authors.forename: M
authors.initials: M
authors.lastname: Cherif
authors.forename: K
authors.initials: K
authors.lastname: Boubaker
authors.forename: M
authors.initials: M
authors.lastname: Mahfoudhi
authors.forename: H
authors.initials: H
authors.lastname: Hedri
authors.forename: M
authors.initials: M
authors.lastname: Ounissi
authors.forename: F
authors.initials: F
authors.lastname: Ben Hamida
authors.forename: F
authors.initials: F
authors.lastname: Ben Moussa
authors.forename: T
authors.initials: T
authors.lastname: Ben Abdallah
authors.forename: F
authors.initials: F
authors.lastname: El Younsi
authors.forename: H
authors.initials: H
authors.lastname: Kâaroud
authors.forename: S
authors.initials: S
authors.lastname: Béji
authors.forename: R
authors.initials: R
authors.lastname: Goucha
authors.forename: H
authors.initials: H
authors.lastname: Ben Maïz
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000502:physiology*; D001795:Blood Pressure Determination; D003928:Diabetic Nephropathies / Q000401:mortality / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D008297:Male; D012044:Regression Analysis; D006435:Renal Dialysis / Q000401:mortality; D016019:Survival Analysis; D013997:Time Factors; D014511:Uremia / Q000401:mortality / Q000628:therapy